These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37290904)
21. The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia. Zamani M; Mohsenpour F; Torkzaban F; Atrvash N; Majlesi A; Torkzaban A J Reprod Infertil; 2023; 24(1):43-48. PubMed ID: 36919051 [TBL] [Abstract][Full Text] [Related]
22. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study. Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849 [TBL] [Abstract][Full Text] [Related]
23. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia? Mora PAR; Sun SY; Velarde GC; Filho JR; Uberti EH; Dos Santos Esteves APV; Elias KM; Horowitz NS; Braga A; Berkowitz RS Gynecol Oncol; 2019 May; 153(2):277-285. PubMed ID: 30857648 [TBL] [Abstract][Full Text] [Related]
24. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia. Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417 [TBL] [Abstract][Full Text] [Related]
25. Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report. Mu X; Yin R; Wang D; Song L; Ma Y; Zhao X; Li Q Medicine (Baltimore); 2018 Sep; 97(38):e12424. PubMed ID: 30235719 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of Combination Therapy with Actinomycin D and Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia. Kang HL; Zhao Q; Yang SL; Duan W Chemotherapy; 2019; 64(1):42-47. PubMed ID: 31163446 [TBL] [Abstract][Full Text] [Related]
27. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. Mao Y; Wan X; Lv W; Xie X Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633 [TBL] [Abstract][Full Text] [Related]
28. Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies. Hao J; Zhou W; Zhang M; Yu H; Zhang T; An R; Xue Y BMC Cancer; 2021 Oct; 21(1):1122. PubMed ID: 34663255 [TBL] [Abstract][Full Text] [Related]
29. Early pregnancy following multidrug regimen chemotherapy in a gestational trophoblastic neoplasia patient: A case report. Niu G; Yuan LJ; Gong FQ; Yang J; Zhu CX; Shen HW Medicine (Baltimore); 2017 Dec; 96(51):e9221. PubMed ID: 29390471 [TBL] [Abstract][Full Text] [Related]
31. Utility of Ovarian Reserve Screening with Anti-Müllerian Hormone for Reproductive Age Women Deferring Pregnancy. Grossman LC; Safier LZ; Kline MD; Chan CW; Lobo RA; Sauer MV; Douglas NC J Womens Health (Larchmt); 2017 Apr; 26(4):345-351. PubMed ID: 27906603 [TBL] [Abstract][Full Text] [Related]
32. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733 [TBL] [Abstract][Full Text] [Related]
33. Five-year study assessing the clinical utility of anti-Müllerian hormone measurements in reproductive-age women with cancer. Palinska-Rudzka KE; Ghobara T; Parsons N; Milner J; Lockwood G; Hartshorne GM Reprod Biomed Online; 2019 Oct; 39(4):712-720. PubMed ID: 31471141 [TBL] [Abstract][Full Text] [Related]
34. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization. Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346 [TBL] [Abstract][Full Text] [Related]
35. The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy. Wu X; Qin J; Shen T; Fei W; Chen L; Xie X; Lu W J Gynecol Oncol; 2020 Jul; 31(4):e36. PubMed ID: 32026657 [TBL] [Abstract][Full Text] [Related]
36. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment. Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251 [TBL] [Abstract][Full Text] [Related]
37. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675 [TBL] [Abstract][Full Text] [Related]
38. Outcome of First-Line Hysterectomy for Gestational Trophoblastic Neoplasia in Patients No Longer Wishing to Conceive and Considered With Isolated Lung Metastases: A Series of 30 Patients. Dabi Y; Hajri T; Massardier J; Mathé M; You B; Lotz JP; Patrier S; Khawajkie Y; Schott AM; Golfier F; Bolze PA Int J Gynecol Cancer; 2018 Nov; 28(9):1766-1771. PubMed ID: 30365454 [TBL] [Abstract][Full Text] [Related]
39. Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women. Uberti EM; Fajardo Mdo C; da Cunha AG; Frota SS; Braga A; Ayub AC Rev Bras Ginecol Obstet; 2015 Jun; 37(6):258-65. PubMed ID: 26200823 [TBL] [Abstract][Full Text] [Related]
40. Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial. You B; Bolze PA; Lotz JP; Massardier J; Gladieff L; Joly F; Hajri T; Maucort-Boulch D; Bin S; Rousset P; Devouassoux-Shisheboran M; Roux A; Alves-Ferreira M; Grazziotin-Soares D; Langlois-Jacques C; Mercier C; Villeneuve L; Freyer G; Golfier F J Clin Oncol; 2020 Sep; 38(27):3129-3137. PubMed ID: 32716740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]